Safety Among Adolescents and Adults of Revaccination With Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed (Adacel) 4 to 5 Years After a Previous Dose
Phase of Trial: Phase IV
Latest Information Update: 14 Jul 2016
At a glance
- Drugs DTaP vaccine (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus Adverse reactions
- Sponsors Sanofi; sanofi pasteur
- 15 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Jun 2007 Status change from recruiting to in progress.
- 28 Oct 2006 New trial record.